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Targeted prevention in primary care aimed
at lifestyle-related diseases: a study
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Abstract
Background: The consequences of lifestyle-related disease represent a major burden for the individual as well as
for society at large. Individual preventive health checks to the general population have been suggested as a mean
to reduce the burden of lifestyle-related diseases, though with mixed evidence on effectiveness. Several systematic
reviews, on the other hand, suggest that health checks targeting people at high risk of chronic lifestyle-related
diseases may be more effective. The evidence is however very limited. To effectively target people at high risk of
lifestyle-related disease, there is a substantial need to advance and implement evidence-based health strategies and
interventions that facilitate the identification and management of people at high risk. This paper reports on a non-
randomized pilot study carried out to test the acceptability, feasibility and short-term effects of a healthcare
intervention in primary care designed to systematically identify persons at risk of developing lifestyle-related disease
or who engage in health-risk behavior, and provide targeted and coherent preventive services to these individuals.
Methods: The intervention took place over a three-month period from September 2016 to December 2016. Taking a
two-pronged approach, the design included both a joint and a targeted intervention. The former was directed at the
entire population, while the latter specifically focused on patients at high risk of a lifestyle-related disease and/or who
engage in health-risk behavior. The intervention was facilitated by a digital support system. The evaluation of the pilot
will comprise both quantitative and qualitative research methods. All outcome measures are based on validated
instruments and aim to provide results pertaining to intervention acceptability, feasibility, and short-term effects.
Discussion: This pilot study will provide a solid empirical base from which to plan and implement a full-scale
randomized study with the central aim of determining the efficacy of a preventive health intervention.
Trial registration: Registered at Clinical Trial Gov (Unique Protocol ID: TOFpilot2016). Registered 29 April 2016. The
study adheres to the SPIRIT guidelines.
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* Correspondence: lblarsen@health.sdu.dk
1Department of Public Health, Research Unit of General Practice, University
of Southern Denmark, Odense, Denmark
Full list of author information is available at the end of the article
© The Author(s). 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Larsen et al. BMC Family Practice  (2018) 19:124 
https://doi.org/10.1186/s12875-018-0820-8
Background
In this paper we report on a non-randomized pilot study
examining the efficacy of a preventive healthcare inter-
vention. The intervention has been designed to system-
atically identify patients at high risk of developing
lifestyle-related disease, and provide targeted and coher-
ent preventive services to these individuals [1].
Lifestyle-related disease refers to health conditions that
are predominantly caused by health-risk behaviors, such as
poor diet, smoking, high consumption of alcohol, or lack
of exercise. The consequences of lifestyle-related disease
represent a major challenge for the individual as well as for
society at large [2]. In Denmark, people who smoke to-
bacco, consume excessive amounts of alcohol, and have a
sedentary lifestyle are nearly seven times as likely to die
from lifestyle-related diseases than physically active
non-smokers with a moderate intake of alcohol [3]. It is es-
timated that 80% of cardio-vascular disease (CVD), type
2-diabetes mellitus (T2DM), and chronic obstructive pul-
monary disease (COPD), and 40% of all cancers may be
averted by maintaining healthy dietary habits, regularly ex-
ercising, and refraining from smoking [4]. Indeed, prevent-
able lifestyle-related diseases account for approximately 50
to 60% of all hospital admissions [5]. It is expected that in-
creasing rates of obesity and physical inactivity will lead to
a surge in the number of patients with lifestyle-related dis-
eases in the decades to come [6–8]. In light of these trends,
there is a substantial need to advance and implement
evidence-based health strategies and interventions that fa-
cilitate the identification and management of people at risk
of developing these diseases [9].
Disease prevention is a central task in general practice in
Denmark and the Nordic countries [10]. Two recent sys-
tematic reviews of general practice health checks suggest
that people at high risk of chronic disease may benefit from
targeted preventive health checks [11, 12]. Indeed, targeted,
or selective, preventive healthcare is a generally accepted
and well-integrated part of healthcare systems worldwide
(e.g. treatment of hypertension and hyperlipidemia). Other
studies, however, suggest that systematic screening of the
general population does not improve clinical endpoints
above and beyond those associated with opportunistic
screening. These studies indicate that, at a population level,
systematic screening of the general population does more
harm than good [13–15]. Overall, however, the evidence
on targeted and systematic screening of chronic disease is
very limited, possibly providing an explanation for the ap-
parent contradictions in the literature. To this end, projects
in the Netherlands and Great Britain are currently under-
way, testing different approaches to targeted and system-
atic intervention in general practice [16, 17].
There is an even greater lack of evidence when it comes
to targeted preventive interventions that comprise both
general practice and community health services. In such
an approach the general practitioner (GP) targets patients
at high risk for lifestyle-related diseases and engages in
risk-management of biomarkers and disease with behavior
change and pharmaceutical interventions when needed.
Community health services, on the other hand, focus pri-
marily on the prevention of health-risk behaviors - includ-
ing tobacco use, poor diet, excessive alcohol consumption,
and sedentary lifestyles - and provide behavior-change in-
terventions such as smoking cessation assistance and diet-
ary advice. Danish studies suggest a potential to enhance
the collaboration and cohesiveness of the various compo-
nents that comprise the preventive healthcare services in
the Danish primary care system – especially between GPs
and community health services [18, 19]. Outside of the Da-
nish context, the benefits of a more unified and coherent
healthcare service have also been advanced in peer-reviewed
studies [20, 21]. However, effectiveness studies of a unified
approach, such as that described above, seem to be lacking.
In 2012, we carried out a feasibility study, testing a novel
approach to population-based risk stratification at four Da-
nish GP clinics [22]. The intervention combined lifestyle
survey data with health record information in order to
identify presumably healthy individuals who nonetheless
were at high risk of developing lifestyle-related diseases.
These individuals were then offered a health check at their
GP for a more definitive assessment of their general health
as well as their risk of developing lifestyle-related diseases.
Results indicated that this approach to preventive action
was indeed feasible, and thus ultimately inspired the devel-
opment of a large randomized study, the present
TOF-project (TOF is a Danish acronym for Early Detection
and Prevention). The principal aim of the upcoming
TOF-project is to examine the efficacy of a preventive
healthcare intervention that systematically identifies indi-
viduals at high risk of lifestyle-related disease, and provides
targeted and coherent preventive services. We expect that
significant changes in the targeting and systematization of
disease prevention in the Danish primary care sector, in-
cluding earlier detection and more coherent preventive ser-
vices, will diminish the individual and societal burden of
chronic disease. Due to the complexity of the TOF inter-
vention, and the relatively high number of stakeholders, a
pilot study needs to be conducted before full-scale imple-
mentation and evaluation [23]. The aim of the pilot study is
to test the acceptability, feasibility, and short-term effects of
a selective preventive program, designed to systematically
help patients evaluate their individual risk of lifestyle-related
disease. The program also offers targeted and coordinated
preventive services in the primary healthcare sector.
Methods
The pilot study was designed as a population based
non-randomized study in the Region of Southern Denmark,
comprising 22 municipalities, 787 GPs, and a general
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population of 1,2 million. The Danish health care system is
a tax-based system comprising three levels: A national level
responsible for, among other things, public health, plan-
ning, and patient safety; a regional level responsible for the
hospitals and the primary care sector; and a municipal level
responsible for primary prevention, rehabilitation, and pa-
tient education. General practice and the municipalities
have shared responsibility for preventive services aimed at
the individual. Specifically, GPs assess patient health and
implement disease-specific secondary prevention. The mu-
nicipalities, however, are tasked with primary prevention
such as smoking cessation, alcohol treatment, and other
lifestyle related services. GPs are organized in clinics with
an average of two GPs per clinic. While most clinics com-
prise a single GP, some have up to ten. Almost all Danish
citizens (98%) are registered with a GP [24, 25]. Each GP
has an average of 1600 registered patients.
Recruitment
The pilot study targets adults born between year 1957
and 1986. All 22 municipalities in the Region of South-
ern Denmark were invited to participate in TOF. Ten
municipalities (Esbjerg, Haderslev, Varde, Sønderborg,
Aabenraa, Middelfart, Kerteminde, Nyborg, Svendborg,
Langeland) submitted expressions of interest to partici-
pate in the study, and were approved for participation by
the Regional Council. Two of the municipalities (Hader-
slev and Varde) volunteered to participate in the pilot
study.
The municipalities of Haderslev and Varde comprise
55,971 and 50,110 citizens, and 37 and 29 GPs, respect-
ively. All GPs from each municipality were invited to an
information meeting before being formally invited to par-
ticipate in the pilot study. The invitation was followed up
with telephone calls to the individual GP clinics. All pa-
tients were invited at baseline, and the intervention was
taken up by the patients at their own convenience during
the intervention period. See Additional file 1 for a more
detailed project flow showing the recruitment, interven-
tion and evaluation phases.
Organization and development of the intervention
The intervention was planned during a two-year com-
bined effort involving all stakeholders. End users were
involved in the design of the intervention, including pa-
tients, GPs, and municipal health professionals. A group
of seven GPs developed the targeted intervention at a
general practice level during five workshops. Similarly, a
group of 10 municipal health workers, one from each of
the participating municipalities, developed the targeted
intervention at a municipal level during 10 workshops.
The workshops lasted between 2 h and 2 days. A digital
support system was created and tested by user populations,
including patients, non-government patient organizations,
GPs, and municipal health professionals.
A steering committee was established at the start of
the project, consisting of managers or board members
from the Region of Southern Denmark (project owner),
The Organization of General Practitioners in Denmark
(PLO), the 10 participating municipalities, the Research
Unit for General Practice at the University of Southern
Denmark (FEA), and the Danish Quality Unit for Gen-
eral Practice (DAK-E). The chair of the committee is the
health director from the Region of Southern Denmark.
A research committee with participation from the steer-
ing committee chair and the primary investigator has
been established. A mission statement has been ap-
proved by the steering committee and an agreement of
co-operation has been signed between the Region of
Southern Denmark and the University of Southern
Denmark. The agreement states that the University of
Southern Denmark holds all rights, intellectual as well
as judicial, to the research data, and that the Region of
Southern Denmark has no right to oppose publication of
results. The research committee approves all access to
research data from affiliated researchers.
Prior to study commencement, all enrolled GPs, prac-
tice nurses (PN), and health professionals from the mu-
nicipalities were invited to a joint three-hour training
course (August 2016). The course focused on the
assigned intervention activities and tasks both within the
GP clinics and the municipality respectively, and be-
tween GPs and the municipality.
Invitation and consent
The source population received an invitation to partici-
pate, sent on behalf of the GP and the municipality to
the individual’s digital mailbox. All permanent residents
in Denmark are obligated to have a digital mailbox,
which is essentially a digital mail-system provided by the
government for secure and direct communication be-
tween individuals and public authorities and other
trusted organizations (e.g. banks and insurance compan-
ies) [26]. People may opt out of the digital mail system,
citing low IT-literacy (usually elderly persons), cognitive
impairment, or other complicating factors. To enroll in
the study, individuals were asked to follow a link in the
invitation to a digital support system protected by a
two-phased NemID password [27]. NemID is a password
system providing an exact identification of the user. This
system is utilized by Danish public and non-public insti-
tutions to provide secure access to personal information,
such as health and financial data. Through digital mail
and NemID, we were able to reach and identify 97% of
the target population. In April 2016, participants re-
ceived an invitation with an embedded hyperlink to a
digital consent form on a secure webpage in their digital
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mailbox. The consent form outlined study participation
and disclosure of data from the GPs electronic patient
record (EPR) and was supplemented with short videos
describing the purpose of the study and the intervention.
Participants were asked to read the information and
electronically sign the consent form. Two reminders
were sent after one and 2 weeks if participants failed to sign
the form. Enrollment closed after 6 weeks. At this time, in-
formation on relevant diagnosis (International Classification
of Primary Care (ICPC-2) codes) and prescribed medicine
(Anatomical Therapeutic Chemical Classification (ATC)
codes incl. Text fields with indication for treatment) were
collected from the GPs EPR system (See Table 1 for the
ICPC-2 codes and ATC codes that were accessed based on
the consent). Five months after consent (September 2016),
participants received another digital invitation in the digital
mailbox, this time to fill in a questionnaire and access a
personal health profile. Participants could opt-out at any
time during the intervention period by clicking an “opt-out”
button on the digital support system.
Intervention
The duration of the intervention was 3 months and took
place between September 2016 and December 2016. The
intervention comprised a two-pronged approach: [1] a
joint intervention applied to the entire sample, regardless
of whether the participants were healthy, at risk, or already
in treatment for T2DM, COPD, CVD, hypercholesterol-
emia or hypertension [2] a targeted intervention that was
offered only to participants who presumably would benefit
from either further examinations at the GP (high risk), or
from receiving community health services, such as smok-
ing cessation, dietary advice, or physical activity (heal-
th-risk behavior).
The joint intervention consisted of:
 Stratification to one of four risk groups. Stratification
to a specific risk group was determined by use of risk
algorithms and EPR information
 A digital support system with user interfaces for all
users, including the patient, the GP, and the municipal
health professional
 An individual health profile
The targeted intervention consisted of:
 A focused clinical examination and a subsequent
health dialogue with a GP (targeting patients at high
risk), and / or
 A short telephone-based health dialogue with a
municipal health professional. For patients with
limited capability to care for their own health,
this initial talk could be followed up with a subse-
quent face-to-face health dialogue (targeting pa-
tients with health-risk behavior)
For all present intents and purposes, the term
health dialogue refers to a consultation that includes
the elements of the 5As model (see Table 1) and the
techniques used in motivational interviewing [28, 29].
The joint intervention
All participants gained access to the digital support sys-
tem and were invited to fill in a questionnaire. The par-
ticipant questionnaire contained 15 items on height,
weight, self-perceived health status, family history of
lifestyle-related diseases, COPD related symptoms,
smoking status, leisure activity level, alcohol consump-
tion, diet, and osteoarthritis risk factors. Questions about
family history of diabetes and leisure activity level were
taken from the Danish Diabetes Risk model [30]. Simi-
larly, questions on COPD-related symptoms and smok-
ing status were derived from the COPD-PS screener [31]
and the Heartscore BMI score [32]. Items tapping diet-
ary habits were from the Swedish National Guidelines
on Disease Prevention [33]. The questionnaire took ap-
proximately 5 min to complete.
Based on the questionnaire and information from
the individual EPR, participants were stratified into
four distinct risk groups:
Group 1 – Participants with a pre-existing diagnosis
and/or in current treatment for a lifestyle-related
disease.
Group 2 – Participants at high risk of developing
lifestyle-related disease, and thus eligible for the offer of
a targeted intervention at the GP.
Table 1 The 5As model
Assess Initial questionnaire-derived assessment of the patients’ health / risk profile for the purpose of identifying patients
in need of health-risk behavior change
Subsequent health examination at the GP to confirm or disprove estimated risk of disease
Advice Counseling, based on the patient’s symptoms / risk profile. The patient’s values and attitudes can usefully be involved
Agree Active involvement of the patient in connection with goal setting regarding health-risk behavior change
Assist Joint development of plan for health-risk behavior change
Arrange follow-up Planning of the next steps at the GP or other (e.g. the municipality)
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Group 3 – Participants engaging in health-risk behavior,
and thus eligible for the offer of a targeted intervention
at the municipality.
Group 4 – Participants with a healthy lifestyle and no
need for further intervention.
Stratification to group 1
EPR data was collected via certified EPR-suppliers. We
used International Classification of Primary Care-2
codes (ICPC-2) registered by the GP and/or Anatomical
Therapeutic Chemical Classification (ATC) codes for
prescribed medicine within the past 2 years, together
with the indication for prescribing the medicine, to iden-
tify Group 1 participants (see Table 2).
Given the pre-existing diagnosis and/or treatment,
Group 1 was excluded from the subsequent risk estima-
tion and stratification into Group 2, 3, and 4.
Stratification to group 2
Next, participants at risk of lifestyle-related disease were
identified using three validated risk scores: the Chronic
Obstructive Pulmonary Disease Population Screener
(COPD-PS), the Danish Diabetes Risk model, and a
modified Heartscore BMI score [30–32]. The COPD-PS
uses an algorithm accounting for age, lifetime use of cig-
arettes, and smoking-related symptoms to identify
at-risk patients who may benefit from a spirometry to
test for COPD (Table 3) [31]. The Danish Diabetes Risk
score is based on an algorithm that incorporates age,
sex, BMI, known hypertension, leisure activity level, and
family history of diabetes (Table 4) [30]. The modified
Heartscore BMI score accounts for age, sex, body mass
index (BMI), and smoking status (Table 5) [32].
Consistent with the criteria of the four distinct stratifi-
cation groups defined above, participants were catego-
rized into Group 2 when one or more of the risk
assessment algorithms indicated high likelihood of de-
veloping lifestyle-related disease (see Tables 3, 4 and 5).
Stratification to group 3 and 4
Finally, participants engaging in health-risk behavior
with one or more risk factors were categorized in Group
3 (Group 3). Health-risk behavior was defined by the
presence of at least one of the following behaviors:
smoking tobacco on a daily basis, consuming more than
14/21 (male/female) standard units of alcohol per week,
sustaining an unhealthy diet (diet score ≤ 4 on a
12-point score drawn from the Swedish National Guide-
lines on Disease Prevention) [4], maintaining a BMI ≥
35, and/or engaging in a generally sedentary lifestyle.
Lastly, participants with no lifestyle-related disease or
risk thereof were stratified into Group 4.
Digital support system
All users had access to a digital support system in the
form of a web page with a common database and spe-
cific user interfaces for the GP, the municipality health
professionals, and the patient. No apps were developed.
The system design drew inspiration from the work by
Krist and colleagues’ research on preventive EPRs, and
was further inspired by the results of a Delphi process
carried out to identify factors for optimal development
of health-related websites [34–36]. Due to challenges in
terms of interoperability between the eight suppliers of
EPR systems used by GPs, and at least three suppliers of
electronic care records (ECR) in the municipalities, it
was not feasible to develop a support system that com-
pletely integrated the EPR and ECR systems. Instead, the
digital support system was developed as a parallel system
with an additional functionality facilitating the transfer
of information (e.g. relating to lifestyle and/or
Table 2 Criteria for identification of participants with a pre-existing diagnosis and/or in current treatment for a lifestyle-related disease
Diagnosis Diagnostic code(s) (ICPC-2) ATC therapeutic code(s) for prescribed medicine and indicative texts for the prescriptiona
Hypertension K86, K87 or C0
*BT*, *bt*, *Bt*, *ypert*, *ldot*, *LODTR*, *lotr*, *lodptr*, *blodtryk*
*bl. trykket*, *lodrtr*b
Hyperlipidemia T93 or C10
*kolesterol*
COPD R95 or R03AC18 (indacaterol), R03AC19 (Olodaterol), R03AL03 (vilanterol),
R03AL04 (Indacaterol+Glycopyrroniumbromide), R03AL05
(Formoterol+Aclidiniumbromide) R03BB04 (tiotropium bromide),
R03BB05 (Aclidiniumbromide), R03BB06 (Glycopyrroniumbromide)
*obstruktiv*, *KOL*
T2DM T90 or A10(diabetes medicine)
*sukkersyge*, *diabetes*
CVD K74, K76c
aThe indicative text is in Danish and has not been translated as some indicative texts are only parts of the entire word and as such not translatable
bThe reason for the large number of indicative text is misspellings by the GP when indicating the purpose of the prescription
cDiagnostic codes for ischemic heart diseases are transferred to the GP’s EPR system when the patients are discharged from the hospital following an angina or a
stroke. ATC codes for prescribed medicine will not provide further information
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prevention plans) to the EPR and ECR systems using
Electronic Data Interchange (EDIfact) messages [22].
The patient controlled access to personal health infor-
mation on the system, such that the GP and municipal
health professional were only able to access this infor-
mation with the explicit consent of the patient.
The digital support system was developed iteratively in
collaboration with the users during the before mentioned
workshops with municipality health professionals and GPs
and in the form of usability tests with patients. The user
interface for the patient was responsive and compatible
with most devices, including mobile phones, tablets, lap-
tops and stationary computers. Due to technical con-
straints in the secure log-in provided by NemID, the user
interface for health professionals was only developed for
laptops and stationary computers. In order to make the
user interface for the patient as intuitive and user-friendly
as possible, the digital support system made extensive use
of simple visualizations, icons, and short information vid-
eos (Fig. 1). The primary text-based messages were kept
short and concise with the provided possibility of acces-
sing secondary in-depth information, retrieved from the
Danish Health Portal, sundhed.dk [37].
Beyond facilitating the intervention, the digital support
system also enabled data collection for research
purposes. A number of questionnaires were sent from
the digital support system to the participants at specific
time-points, including immediately after consent, after
receiving the personal health profile, following the health
dialogue at the GP, and at the end of the implementation
period. Questionnaire reminders were sent by e-mail
with a link to the digital support system. The GPs and
municipal health professionals received audits in the
form of short questionnaires immediately after each con-
sultation as well as before and after the study period
(GPs only).
Personal health profile
Based on results of the stratification process, each pa-
tient received a personal health profile on the digital
support system. The purpose of the health profile was
to encourage patients to change their health-risk be-
havior and follow the tailored advice provided by the
system. Patients who were at increased risk of devel-
oping a lifestyle-related disease (Group 2) were ad-
vised to consult their GP for further examination and
advice. Similarly, patients engaging in health-risk be-
havior (Group 3) were offered lifestyle counseling, or
lifestyle courses from the municipality health services.
Table 3 Algorithm used for risk assessment of COPD
Characteristic Score
During the past 4 weeks, how much of the time did you feel
short of breath during every day activities? (e.g. Strolling, light
gardening, cleaning, shopping etc.)
None of the time 0
A little of the time 0
Some of the time 1
Most of the time 2
All of the time 2
Do you ever cough up any “stuff,” such as mucus or phlegm? No, never 0
Only when I have a cold, pneumonia or sore throat 0
Yes a few days a month 1
Yes most days a week 1
Yes every day 2
Please select the answer that best describes you in the past
12 months. I do less than I used to because of my breathing
problems.
Strongly disagree 0
Disagree 0
Unsure 0
Agree 1
Strongly agree 2
Have you smoked at least 100 cigarettes in your ENTIRE LIFE? Yes 2
No 0
Age 35–49 years 0
50–59 years 1
60–69 years 2
+ 70 years 2
Cut off value: ≥5
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By definition, Group 4 patients lead a relatively
healthy life with no need for health-risk behavior
change. Group 1 patients were advised to continue
their treatment and use the information provided to
change health-risk behavior.
The personal health profile included individualized
information on current health-risk behavior and risk of
disease. The information was tailored based on the
questionnaire, the information from the EPR, and the
risk scores on COPD, T2DM, and CVD. It also in-
cluded general health information and information
about preventive health services concerning smoking,
diet, exercise, and alcohol consumption. This informa-
tion was provided by the municipality, the Region of
Southern Denmark, or national health services, and tar-
geted the individual (e.g. via links to apps and web-
pages) based on his/her specific health-risk behavior.
The targeted intervention
The intervention at the GP
The intervention at the general practice level consisted of a
focused clinical examination and a subsequent health dia-
logue and was offered to patients who were at increased
risk of developing a lifestyle-related disease (Group 2).
Group 2 patients accepted the offer of the intervention by
scheduling an appointment at the GP (either by phone or
the GP’s webpage). Whether the patient participated in the
intervention or not was thus determined by their motiv-
ation and capabilities as well as the extent to which the
content of the personal health profile motivated the patient
to take action. The intervention was applied within the
framework of the 5As model (see Table 1) [28]. The content
of the focused clinical examination was based on the pa-
tient’s health profile, and might include measurements of
blood glucose (HbA1c) and cholesterol levels, as well as
Table 4 Algorithm used for risk assessment of T2DM
Characteristic Score
Sex
Male 1
Female 0
Age
40–44 years 0
45–49 years 1
50–54 years 2
55–59 years 3
60–69 years 4
BMI
25–30 kg/m2 1
> 30 kg/m2 2
Known hypertension
Yes 2
No 0
Primary recreational activity level during the past year:
Participating in sports competitions or hard exercise several times a week 0
Active with sports at least three times a week or regularly perform heavy house or garden work 0
Strolling, cycling or other light exercise at least 4 h a week (including Sunday walks, light gardening and cycling/walking to work) 1
Reading, watching television or other sedentary jobs 1
Family history of diabetes (Family includes grandparents, parents, sibling and children):
No family member with diabetes before the age of 70 0
One family member with diabetes before the age of 70 1
More than one family member with diabetes before the age of 70 2
Having had diabetes including gestational diabetes
Yes 2
No 0
Cut off value: ≥5
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height, weight, blood pressure, and lung function measure-
ments and Electrocardiogram (ECG). Results from the
examinations were registered in the digital support system
where both the patient and the GP could access them at
any time. After the focused clinical examination all patients
were given the opportunity to prepare for the subsequent
health dialogue by answering a questionnaire inspired by
three systematic reviews on the determinants of behavior
change [38–40]. These included questions about motiv-
ation, resources, former experiences with behavior change,
Table 5 Algorithms used for risk assessment of CVD
Age BMI Daily smoker
Female
> 50 years > 40 kg/m2 +
> 55 years > 40 kg/m2 –
> 58 years 35–40 kg/m2 +
Male
> 49 years > 40 kg/m2 +
> 55 years > 40 kg/m2 –
> 50 years 35–40 kg/m2 +
> 55 years 35–40 kg/m2 –
> 52 years 30–35 kg/m2 +
> 56 years 25–30 kg/m2 +
Fig. 1 Screen dump from digital support system (in Danish)
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social network, mental health (WHO-5 for stress and
Major Depression Inventory (MDI) for depression) [41, 42],
and a scheme to qualitatively self-report on facilitators and
barriers to behavior change (a so-called balance-sheet). The
questionnaire results were shared with the GP on the digital
support system. Based on the health dialogue, the GP and
the patient developed a prevention plan that included a
goal, a time frame, and identification of the appropriate
means to fulfill the plan (e.g. reference to a smoking cessa-
tion course, or follow-up at the GP). The prevention plan
was registered on the digital support system by the GP and
was accessible to both the GP and the patient.
The intervention at the municipal level
The intervention at the municipal level was offered to
patients exhibiting health-risk behavior (Group 3) and
consisted of a short telephone consultation with a health
professional – for example a nurse, a dietician, or a
physiotherapist. A subsequent face-to-face health dia-
logue was offered to patients who were deemed to po-
tentially benefit from more extensive support. Group 3
patients requested the intervention on the digital sup-
port system by filling in a short form and sending it by
e-mail to the municipality. A municipal health profes-
sional would then call the patient within the following
week. Similar to the GP intervention, the intervention at
the municipal level was thus also determined by patient
motivation and capabilities as well as the extent to which
the content of the personal health profile motivated the
patient to take action. Immediately after the interven-
tion, a participation form was sent to the municipality.
Patients could prepare for the upcoming call from a mu-
nicipal health professional in the same way as Group 2
patients prepared for the health dialogue – that is, by
answering a short questionnaire. Ultimately, a preven-
tion plan, including concrete details on its execution,
was developed based on the telephone consultation and
the face-to-face health dialogue. The prevention plan
was registered by the municipal health professional and
presented on the user interfaces of both the municipality
and the patient.
Sample size calculation
While aiming to test the acceptability, feasibility, and
short-term effects of the pilot, we estimated a sample
size for each GP that would allow the GP to familiarize
him/herself with the intervention without unnecessary
increases in workload during the intervention period. In
agreement with the GP representative in the Region of
Southern Denmark, we set a target of four health checks
for each GP. From the feasibility study, we estimated
that 60% would consent to the study, and that 75% of
these participants would receive a personal digital health
profile [22]. Also based on the feasibility study, we
estimated that 12% of the study population would be
recommended to consult their GP (Group 2). From re-
sults obtained in similar Dutch studies, we finally esti-
mated that 35% of the these patients (Group 2) would
eventually consult the GP [43]. Given these figures, we
calculated that a total sample of approximately 200 pa-
tients from each GP would be required to reach the tar-
get of four completed health checks per GP.
Data collection and analysis
Evaluation outcomes
Evaluation of the study will be carried out using quanti-
tative as well as qualitative research methods (Table 6).
All outcome measures are based on validated instru-
ments and aim to provide results pertaining to interven-
tion acceptability, feasibility, and short-term effects. In
addition, outcomes related to other associated topics will
be included. The specific instruments used will be de-
scribed in detail in later publications.
Qualitative data
Qualitative data will be derived from interviews (individual
and focus groups comprising GPs, practice staff members,
municipality staff members, patients from group 2 and 3,
stakeholders, project leaders and researchers) and partici-
pant observations (during the health dialogues at the GP).
The estimated number of participants is shown in Table 6.
Quantitative data
Quantitative data will be derived from questionnaires as
well as Danish National registers (see section below).
Table 7 shows the content of the questionnaires applied
while a diagram, attached as Additional file 1, shows a flow
of the entire intervention and the timing of the question-
naires during the intervention.
Register based data
Data from the Danish national registers concerning
demographic information, prescriptions, and health care
usage of the target population (n = 9.400) will be ob-
tained from Statistics Denmark (https://www.dst.dk/da)
[44]. Information from the different registers will be
linked by the patients’ Danish Personal Identification
Number.
Socio-demographic variables
Information on socio-demography encompassed educa-
tional level, occupation, income, cohabitation status, eth-
nicity, and residency.
Education is defined as the highest formal educational
attainment obtained on the first of October in each cal-
endar year.
Occupation is defined as the occupational status on
the first of November in each calendar year.
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Table 6 Outcomes
Outcome Data input
Change in proportion of patients at increased risk
of lifestyle related disease from baseline to the
12 weeks follow up
Questionnaire at baseline (Q2) and end of study period (Q6 and Q7).
Risk of lifestyle related disease is based on the algorithms previously
described in the methods section and in Tables 3, 4 and 5
Determinants of participation and non-participation Questionnaire at baseline (Q2). Participants and non-participants will
be compared with regard to socio-demographic characteristics,
morbidity and contextual characteristics
Evaluation of the digital support system with focus
on design, usability and effect of the decision
support system
Focus group interviews before study start comprising 6 GPs, 6 practice
staff members, 6 municipality staff members, 6–8 patients and
representatives from 6 to 8 stakeholder organizations, respectively
Qualitative interviews with 8–10 patients before and after the health
dialogue at the GP, and qualitative interviews with 6–8 GPs after health
dialogues, focusing on the experienced usefulness of the digital support
system
Questionnaire to all participating patients immediately after signing the
consent form (Q1) and after receiving the health profile (Q3 and Q4)
and to all participating GPs and municipality staff members following
each study related patient encounter (Q8-Q13)
Process evaluation focusing on the intervention
in general practice and the municipality
Participant observation of 10–15 health dialogues in different general
practices, followed by qualitative interviews with the participating
patients, GPs and practice staff
Focus group interviews with 6–8 municipality staff members involved
in the study and interviews with 10–15 patients who have attended a
health dialogue in the municipality
Questionnaire to all participating GPs, practice staff members and
municipality staff members following each study related patient
encounter (Q8-Q13)
Process evaluation focusing on the organizational
basis of the pilot implementation
Interviews with stakeholders involved in the planning, implementation
and evaluation of the study; GPs, practice staff members, municipality
staff members, patients, project leaders, researchers
Process evaluation focusing on the common training
course for enrolled GPs, practice staff and health
professionals from the municipalities
Interviews with GPs and municipal health professionals and
questionnaire at the end of the course
GP and patients preferences with regard to the
content of the health dialogue, and change in
preferences during the study period
Questionnaire using discrete choice modelling (Q4, Q7, Q8, Q11)
Patients’ perceptions of relational empathy following
the health dialogue at the GP
Questionnaire including The Consultation And Relational Empathy
(CARE) measure following each behavior counseling session in general
practice (Q5)
Quality of Life Subscale on the Hip injury and
Osteoarthritis Outcome Score (HOOS)/Knee Injury
and Osteoarthritis Outcome Score (KOOS)
Questionnaire at baseline (Q2). Participants replying “yes” to any of the
osteoarthritis related questions on hip/knee pain, GP care seeking or
surgery at baseline will receive additional questions on knee/hip related
quality of life and mechanical alignment of the leg and foot [55]
Patient enablement following the health dialogue at the GP Questionnaire with Patient Enablement Instrument (PEI) (Q5)
Patient reported 1. Meaning-Making and Health,
2. Spiritual Wellbeing, 3. Religious belief and practices
Questionnaire items are sampled from the validated questionnaire SoMe
(Sources of Meaning) and European Value Study (EVS) (Q6 and Q7)
GP reported 1. Perceived importance of communication
on existential and spiritual issues, 2. Self-efficacy and
barriers in communication on existential and spiritual
issues, 3. Personal belief
Questionnaire items sampled from the validated Self-efficacy
questionnaire, European Value Study (EVS) and two items
developed for this study evaluation (Q6 and Q7)
Patient reported self-efficacy and change in self-efficacy
during the study period as a result of participation
Questionnaire incl. The General Self-Efficacy Scale (Q3, Q4, Q6 and Q7)
Patient reported mental well-being and change in
mental well-being during the study period as a result
of participation
Questionnaire incl. The Warwick-Edinburgh Mental Well-being Scale
(WEMWBS) (Q3, Q4, Q6 and Q7)
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OECD-adjusted income level is defined as the individ-
ual’s/family’s disposable income, adjusted for family size
and categorized in relative terms (low/middle/high in-
come) [45].
Cohabitation status is defined as cohabitating or liv-
ing alone.
Ethnicity is based on country of origin and descendance.
Morbidity
Information on health/disease status (hypertension, hyper-
cholesterolemia, type-2 diabetes, cardio-vascular disease)
is defined in terms of ICD-10 diagnosis codes and medical
usage. The ‘National Patient Registry’ will provide infor-
mation on ICD-10 diagnostic codes. The ‘Register of Me-
dicinal Product Statistics’ provide information on medical
usage [46, 47].
Contextual variables
Contextual variables include information on study site
and neighborhood social deprivation. Neighborhood so-
cial deprivation will be derived on a census district level
and is principally defined in terms of the following three
variables: educational attainment, employment status
(employed/social welfare), and income (mean family dis-
posable income). Educational, employment, and income
deprivation thus specifically refer to the proportion of
citizens within each census district who has access to
basic education (up to high school), who is unemployed
(e.g. students, unemployed workers), and who belongs to
the lowest income quartile, respectively. Each variable is
ranked, grouped in quartiles, and given a value between
0 and 3 (3 = high deprivation). This results in an aggre-
gated ranking system ranging from 0 (low deprivation)
to 9 (high deprivation). The aggregated rank is then
grouped in quartiles. A neighborhood social deprivation
score will be calculated for all census districts in
Denmark in order to obtain local deprivation scores that
mirror the relative social deprivation of the individual
census district [48].
Discussion
This pilot study will provide a solid empirical base from
which to plan and implement a full-scale randomized
study with the central aim of determining the efficacy of
a preventive health intervention. The intervention was
designed to systematically identify persons at risk of
Table 7 The study questionnaires: Target groups and questionnaire items
Target group Questionnaire Items
Patients Q1 Attitudes towards prevention, Risk-taking attitudes, Time preferences, Mental well-being, Self-efficacy,
Evaluation of invitation and consent form
Q2 Height, Weight, Self-perceived health status, Family history of lifestyle-related diseases, Known hypertension,
COPD related symptoms, Osteoarthritis related risk factors, Smoking status, Leisure activity level, Alcohol
consumption, Eating habits
Q3 Evaluation of the personal health profile
Q4 Evaluation of the personal health profile, Preferences with regard to the content of the health dialogue
Q5 Patient Enablement Instrument, The Care Measurement
Q6 Height, Weight, Self-perceived health status, Family history of lifestyle-related diseases, Known hypertension,
COPD related symptoms, Osteoarthritis related risk factors, Smoking status, Leisure activity level, Alcohol
consumption, Eating habits, Attitudes towards prevention, Mental well-being, Self-efficacy, Study
participation, Study evaluation, Meaning-Making and Health, Spiritual Wellbeing, Religious belief and
practices, Risk-taking attitudes, Time preferences
Q7 Height, Weight, Self-perceived health status, Family history of lifestyle-related diseases, Known hypertension,
COPD related symptoms, Osteoarthritis related risk factors, Smoking status, Leisure activity level, Alcohol
consumption, Eating habits, Attitudes towards prevention, Mental well-being, Self-efficacy, Study participation,
Study evaluation, Meaning-Making and Health, Spiritual Wellbeing, Religious belief and practices, Risk-taking
attitudes, Time preferences, Preferences with regard to the content of the health dialogue
GPs Q8 Attitudes towards prevention, Experiences with prevention, Preferences with regard to the content of the
health dialogue, GPs health-risk behavior
Q9 Content of the clinical examination, Staff and time consumption
Q10 Evaluation of the quality of the stratification, Use and evaluation of the digital support system, The patients
motivation and resources, The plan for the patient, Time consumption
Q11 Attitudes towards prevention, Experiences with prevention, Preferences with regard to the content of the
health dialogue
Municipality
health professionals
Q12 Evaluation of the quality of the stratification, Use and evaluation of the digital support system, The patients
motivation and resources, The plan for the patients, Time consumption
Q13 Evaluation of the quality of the stratification, Use and evaluation of the digital support system, The patients
motivation and resources, The plan for the patient, Time consumption
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developing lifestyle-related disease or who engage in
health-risk behavior, and provide targeted and coherent
preventive services to these individuals.
Strengths and limitations
Much effort has been made to define the specific nature
and objective of pilot and/or feasibility studies. In a
scoping review of optimization strategies for complex in-
terventions prior to randomized trials, Levati asserts the
notion that different frameworks for intervention devel-
opment, such as intervention mapping and the MRC
framework for complex intervention, call for different
approaches to pilot and feasibility studies [49]. As a
common feature when developing complex randomized
trials, the authors suggest “that the acceptability of the
intervention to those directly involved in the delivery
and receipt of the final intervention, together with the
anticipated effect of the intervention, are important ele-
ments to take into account as early as possible in the
pre-trial stage.” [49].
Eldridge et al. used a Delphi survey to arrive at distinct
definitions of feasibility and pilot studies [1]. They sug-
gest that “feasibility study” is an overarching term with
“pilot study” representing a subset of feasibility studies.
Generally, feasibility studies ask whether something can
be done, should we proceed with it, and if so, how? Pilot
studies ask the same questions, but with a specific de-
sign feature of a larger study, conducted on a smaller
scale. According to the authors, pilot studies can be sep-
arated in two distinct types: non-randomized and ran-
domized. Non-randomized pilot studies do not include a
control group and are usually external to the subsequent
randomized controlled trial (RCT), that is, the partici-
pants are not included in the effect analysis of the RCT.
Randomized pilot studies, on the other hand, randomize
participants to an intervention or control group and can
be internal to the subsequent RCT. Bowen et al. comple-
ment the work of Eldridge et al. and propose eight foci
(design features) of feasibility studies: Acceptability, de-
mand, implementation, practicality, adaptation, integra-
tion, expansion, and limited efficacy [50].
According to Eldridge et al., the study presented in this
paper is a non-randomized pilot study. We chose a
non-randomized design in order to examine the specific de-
sign features of a stepped wedge cluster randomized design
for the full-scale randomized study. A stepped-wedge de-
sign is a type of cluster randomized design that meets the
specific ethical and logistical demands of a delayed inter-
vention performed in routine care where all participants
will be offered the intervention [51]. The pilot resembles
one cluster in a stepped wedge cluster randomized study,
and will thus allow us to ascertain whether the intervention
can be delivered during a three-month period, or if longer
time is required to avoid carry-over effects [51]. In the
event that more time is necessary to deliver the interven-
tion, it will be difficult, if not impossible, to accurately de-
termine the optimal duration of a cluster. This will likewise
complicate the stepped wedge design. One way to compen-
sate for incomplete knowledge on the optimal timeframe
for the intervention may be to include a “wash out” period
after every cluster allowing for any delay or lag in imple-
mentation before the next cluster is commenced [52]. The
length of the “wash out” period can be estimated from the
results of the pilot study.
We have randomly sampled 200 patients from each
GP in order to have a source population that is repre-
sentative of the target population. We have chosen to
target people born between 1957 and 1986 to assess the
risk of lifestyle-related disease and health-risk behavior
at an age interval where changes in lifestyle will provide
significant health effects and be cost-effective. To this
end, we have chosen to assess variation in the propor-
tion of patients at increased risk of lifestyle-related dis-
ease between baseline and the 12-week follow up as our
primary health-related outcome. Further, given the fact
that complex interventions, such as the one described
here, usually have concurrent endpoints [23], we also
collect data on a variety of other variables – both ques-
tionnaire- and register-based – related to both lifestyle
and disease. We have yet to determine which of these
endpoints to include in the full-scale randomized study.
We have planned the intervention in collaboration with
the stakeholders, patients, and service providers in order to
run a pilot study that is both acceptable and relevant for all
user groups. We use quantitative as well as qualitative re-
search methods to assess the acceptability, demand, imple-
mentation, and practicality of the pilot, from the viewpoint
of both users and service-providers. In addition to evaluat-
ing the intervention, we assess the organizational challenges
of planning and implementing IT-supported pilot studies
[53]. At the same time we test different methods of data
collection, including electronic collection of data from the
digital support system and participant observations at the
GP clinics. We also test various types of questionnaires, in-
cluding ones that involve simple items with binary out-
comes as well as others in more complex discrete
choice format. The pilot will hence enable us to assess
whether the intervention can be executed, and whether
the organizational approach taken, fit the purpose. We
will further be able to make an informed decision about
how we can collect data during the full-scale study in
the most efficient and cost-effective way that is also ac-
ceptable to both users and service-providers.
From pilot to full-scale randomized study
Another issue raised by Levati et al. and Eldridge et al.
concerns pinpointing the appropriate time to move from
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piloting to full-scale RCT. That is, should we proceed
with the project, and if so, how? [1, 49]. Proceeding from
pilot to a full-scale randomized study is probably the
most under-researched part of the implementation of
complex interventions. Bugge et al. suggest a three step
process to establish the best possible foundation on
which to make a decision to advance a full-scale ran-
domized study [54]. First, any problems should be cate-
gorized into three distinct types: Issues that are likely to
complicate the full-scale study, issues that are likely to
complicate both trial and real-world situations, and is-
sues that are likely to complicate real-world situations
only. Next, potential solutions should be identified for
the expected issues, ideally with lay participation. Finally,
the best of these solutions should be selected to deter-
mine the best way to proceed. With this strategy in
mind, we will do a thorough assessment of the problems
encountered in the pilot before advancing the full-scale
study. We will thus identify solutions in collaboration
with the service providers (GPs and municipal health
professionals) who participated in the pilot study, as well
as with those who took part in the design of the inter-
vention. We will also seek patient-feedback on the tech-
nical and communicative properties of the digital
support system before defining its final specifications.
The final assessment is presented to the steering com-
mittee that will take the decision on the way forward.
Additional file
Additional file 1: Detailed project flow showing the recruitment,
intervention and evaluation phases. Detailed project flow from recruitment
to intervention and evaluation. It shows how participants will be recruited,
how they will be stratified using algorithms and what intervention elements
the participant will receive. Furthermore, it shows when quantitative data
will be collected for evaluative purposes. (TIF 1491 kb)
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